남성 근로자의 비만이 adiponectin과 leptin의 생리적 농도와 대사증후군 진단지표에 미치는 영향
Effects of Obesity on the Physiological Levels of Adiponectin, Leptin and Diagnostic Indices of Metabolic Syndrome in Male Workers
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to examine the effects of obesity on the physiological levels of adiponectin, leptin and components of metabolic syndrome (MS) in male workers, aged 30-40 years. Methods: Body mass index (BMI) was measured with Anthropometric equipment. Blood pressure and serum parameters were measured with an automatic digital sphygmomanometer and autochemical analyzer, respectively. Adiponectin and leptin were analysed by ELISA kits and MS was defined based on the NCEP-ATP III. Results: Body fat mass of waist and hip, systolic and diastolic blood pressure were significantly higher, as expected, in the BMI＞ 25㎏/㎡ in comparison with the BMI≤25㎏/㎡. While fasting glucose, insulin, HOMA-IR and leptin in the BMI＞25㎏/㎡ were also significantly higher compared with BMI≤25㎏/㎡, HDL- cholesterol and adiponectin were significantly higher in BMI≤25㎏/㎡. On multiple logistic regression analysis for the components of MS, exercise, adiponectin and leptin were an only independent factor for MS in non-obese male workers(BMI≤25㎏/㎡) after adjustment for age, cigarette smoking and drinking habits. Conclusion: These results suggested that the obesity in men was associated with physiological levels of adiponectin and leptin contributing to feedback control of MS and that dysfunction and/or declination in feedback control system associated with changes in physiological levels of neurptrophics: adiponectin and leptin might ultimately induce MS.
Abstract
Purpose: The aim of this study was to examine the effects of obesity on the physiological levels of adiponectin, leptin and components of metabolic syndrome (MS) in male workers, aged 30-40 years. Methods: Body mass index (BMI) was measured with Anthropometric equipment. Blood pressure and serum parameters were measured with an automatic digital sphygmomanometer and autochemical analyzer, respectively. Adiponectin and leptin were analysed by ELISA kits and MS was defined based on the NCEP-ATP III. Results: Body fat mass of waist and hip, systolic and diastolic blood pressure were significantly higher, as expected, in the BMI＞ 25㎏/㎡ in comparison with the BMI≤25㎏/㎡. While fasting glucose, insulin, HOMA-IR and leptin in the BMI＞25㎏/㎡ were also significantly higher compared with BMI≤25㎏/㎡, HDL- cholesterol and adiponectin were significantly higher in BMI≤25㎏/㎡. On multiple logistic regression analysis for the components of MS, exercise, adiponectin and leptin were an only independent factor for MS in non-obese male workers(BMI≤25㎏/㎡) after adjustment for age, cigarette smoking and drinking habits. Conclusion: These results suggested that the obesity in men was associated with physiological levels of adiponectin and leptin contributing to feedback control of MS and that dysfunction and/or declination in feedback control system associated with changes in physiological levels of neurptrophics: adiponectin and leptin might ultimately induce MS.
참고문헌 (31)
- 국민건강영양조사 제3기 조사결과 심층분석 연구 보고서, "보건복지부 질병관리본부", ~ (2007)
- 2007 국민건강통계: 국민건강영양조사 제4기 1차년도, "보건복지가족부 질병관리본부", ~ (2008)
- 이현진, "보건소 비만 프로그램을 통한 성인 여성의 체지방 변화에 따른 건강상태 및 식생활 비교", 석사, pp.2007
- Alberti, K. G., "Metabolic syndrome: A new worldwide definition. A consensus statement from the International Diabetes Federation", Diabet Med, 23, pp.469~480 (2006)
- Arita, Y., "Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity", Biochem Biophys Res Commun, 257(1), pp.79~83 (1999)
- Avramoglu, R. K., "Lipid and lipoprotein dysregulation in insulin resistant states", Clin Chim Acta, 368, pp.1~19 (2006)
- Berg, A. H., "The adipocyte-secreted protein Acrp30 enhance hepatic insulin action", Nat Med, 7, pp.947~953 (2001)
- Cassis, L. A., "Characterization and regulation of angiotensin II receptors in rat adipose tissue. Angiotensin receptors in adipose tissue", Adv Exp Med Biol, 396, pp.39~47 (1996)
- Chen, H., "Regulation of hypothalamic NPY by diet and smoking", Peptide, 28, pp.384~389 (2007)
- Cordero, A., "Comparison of serum lipid values in subjects with and without the metabolic syndrom", Am J Cardiol, 102, pp.424~428 (2008)
- DeFronzo, R, A., "Obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease", Diabetes Care, 14(3), pp.173~194 (1991)
- National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults, "Executive summary of the third report of the National Cholesterol Education Program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ)", JAMA, 28, pp.2486~2497 (2002)
- Fasshauer, M., "Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes", Biochem Biophys Res Commun, 301(4), pp.1045~1050 (2003)
- Fruhbeck, G., "Role of adipocytokines in metabolism and disease", Nutr Res, 24, pp.803~826 (2004)
- Gable, D. R., "Adiponectin and its gene variants as risk factor for insulin resistance, the metabolic syndrome and cardiovascular disease", Atherosclerosis, 188, pp.231~244 (2006)
- Kamohara, S., "Acute stimulation of glucose metabolism in mice by leptin treatment", Nature, 389, pp.374~377 (1997)
- Koebnick, C., "Leptin-to-adiponectin ratio as independent predictor of insulin sensitivity during growth in overweight Hispanic youth", J Endocrinol Invest, 30(7), pp.RC13~RC16 (2007)
- Koerner, A., "Adipocytokines: leptin-the classical, resistin- the controversical, adiponectin-the promising, and more to come", Best Practice & Research Clinical Endocrinology & Metabolism, 19(4), pp.525~546 (2005)
- Krakoff, J., "Inflammatory markers, adiponectin, and risk of type 2 Diabetes", Diabetes Care, 26, pp.1745~1751 (2003)
- Krauss, R. M., "Obesity: impact on cardiovascular disease", Circulation, 98(14), pp.1472~1476 (1998)
- McCarty, M. F., "Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians", Medical Hypotheses, 72, pp.647~651 (2009)
- Pischon, T., "Plasma adiponectin levels and risk of myocardial infarction in men", JAMA, 291, pp.1730~1737 (2004)
- Poirier, P., "Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss", Arterioscler Thromb Vasc Biol, 26(5), pp.968~976 (2006)
- Ruderman, M., "The metabolically obese, normal-weight individual revisited", Diabetes, 47, pp.699~713 (1998)
- Ryo, M., "Adiponectin as a biomarker of the metabolic syndrome", Circ J, 68, pp.975~981 (2004)
- Sims, E. A., "Are there persons who are obese, but metabolically healthy?", Metabolism, 50, pp.1499~1504 (2001)
- Singhal, A., "Influence of leptin on arterial distensibility: A novel link between obesity and cardiovascular disease?", Circulation, 106(15), pp.1919~1924 (2002)
- Tilg, H., "Adipocyto- kines: Mediators linking adipose tissue, inflammation and immunity", Nature Reviews Immunology, 6, pp.772~783 (2006)
- Van Gaal, L. F., "Mechanisms linking obesity with cardiovascular disease", Nature, 444, pp.875~880 (2006)
- Xita, N., "The adiponectin-to-letin ratio in women with polycystic ovary syndrome: Relation to insulin resistance and proinflam- matory markers", Metab Clin Experimental, 56, pp.766~771 (2007)
- Zhou, Q., "Comparison od adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities", Diabetes Research and Clinical Practice, 84, pp.27~33 (2009)